Is transient elastography valuable for high-risk esophageal varices prediction in patients with hepatitis-B-related cirrhosis?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 3, 2012, Pages 533-539

  Chen, Yong Peng ^a,b   Zhang, Qi ^a   Dai, Lin ^a   Liang, Xie Er ^b   Peng, Jie ^a,b   Hou, Jin Lin ^a,b  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal varices; Hepatitis B; Liver stiffness measurement; Predicting algorithm

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; ELASTOGRAPHY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEPATITIS B; HIGH RISK PATIENT; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM;

EID: 84863181595     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06889.x     Document Type: Article

References (28)

1. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493-96.
2. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N. Engl. J. Med. 1988; 319: 983-89.
3. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 2005; 43: 167-76.
4. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J. Hepatol. 2008; 48 (Suppl. 1): S68-92.
5. Garcia-Tsao G, Sanyal AJ, Grace ND etal. Prevention and management of gastro-esophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-38.
6. Groszmann RJ, Garcia-Tsao G, Bosch J etal. Beta blockers to prevent gastroesophageal varices in patients with cirrhosis. N. Engl. J. Med. 2005; 353: 2254-61.
7. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin. Liver Dis. 1999; 19: 475-505.
8. Giannini E, Botta F, Borro P etal. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-5.
9. Giannini EG, Zaman A, Kreil A etal. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am. J. Gastroenterol. 2006; 101: 2511-19.
10. Berzigotti A, Gilabert R, Abraldes J etal. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am. J. Gastroenterol. 2008; 103: 1159-66.
11. Gentile I, Viola C, Graf M etal. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. J. Clin. Gastroenterol. 2009; 43: 81-7.
12. Kazemi F, Kettaneh A, Kontchou G etal. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J. Hepatol. 2006; 45: 230-5.
13. Vizzutti F, Arena U, Romanelli RG etal. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-7.
14. Castera L, le Bail B, Roudot-Thoraval F etal. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J. Hepatol. 2009; 50: 59-68.
15. Kim BK, Han KH, Park JY etal. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am. J. Gastroenterol. 2010; 105: 1382-90.
16. Marcellin P, Ziol M, Bedossa P etal. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29: 242-47.
17. Chan HL, Wong GL, Choi PC etal. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J. Viral Hepat. 2009; 16: 36-44.
18. Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J. Ultrasound Med. 2002; 21: 1023-32.
19. Chen YP, Dai L, Wang JL etal. Model consisting of ultrasonographic and simple blood indexes accurately identify compensated hepatitis B cirrhosis. J. Gastroenterol. Hepatol. 2008; 23: 1228-34.
20. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003; 29: 1705-13.
21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics 1988; 44: 837-45.
22. Friedrich-Rust M, Ong MF, Martens S etal. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
23. Foucher J, Chanteloup E, Vergniol J etal. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.
24. Talwalkar JA, Kurtz DM, Schoenleber SJ etal. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2007; 5: 1214-20.
25. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002; 35: 478-91.
26. Pinzani M, Gentilini P. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Semin. Liver Dis. 1999; 19: 397-410.
27. Rockey DC, Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 1996; 24: 233-40.
28. ® in patients with hepatitis B exacerbation. J. Viral Hepat. 2010; doi:10.1111/j.1365-2893.2010.01389.x. [Epub ahead of print].